219 related articles for article (PubMed ID: 1692981)
41. Pyridinoline cross-linked carboxyterminal telopeptide of type I collagen as a useful marker for monitoring metastatic bone activity in men with prostate cancer.
Noguchi M; Noda S
J Urol; 2001 Sep; 166(3):1106-10. PubMed ID: 11490307
[TBL] [Abstract][Full Text] [Related]
42. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
43. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
Lange PH; Brawer MK
Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
[No Abstract] [Full Text] [Related]
44. [Advanced prostate cancer with normal serum prostate-specific antigen values].
Komura T; Yamagiwa K; Ogura H; Kohjimoto Y; Ohkawa T; Inagaki T; Ebisuno S; Senzaki A
Hinyokika Kiyo; 1998 May; 44(5):303-6. PubMed ID: 9656099
[TBL] [Abstract][Full Text] [Related]
45. [Early detection of prostatic cancer].
Weissbach L
Urologe A; 1992 Jul; 31(4):193-4. PubMed ID: 1381124
[No Abstract] [Full Text] [Related]
46. [Usefulness of prostatic specific antigen (PSA) for diagnosis and staging of patients with prostate cancer].
Placer J; Morote J
Arch Esp Urol; 2011 Oct; 64(8):659-80. PubMed ID: 22052750
[TBL] [Abstract][Full Text] [Related]
47. Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.
Shariat SF; Scherr DS; Gupta A; Bianco FJ; Karakiewicz PI; Zeltser IS; Samadi DB; Akhavan A
Arch Esp Urol; 2011 Oct; 64(8):681-94. PubMed ID: 22052751
[TBL] [Abstract][Full Text] [Related]
48. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.
Saad F; Pantel K
Future Oncol; 2012 Mar; 8(3):321-31. PubMed ID: 22409467
[TBL] [Abstract][Full Text] [Related]
49. [Specific prostatic antigen: usefulness in clinical practice].
Isa Kroon WA; Sánchez de la Muela PL; Berian Polo JM
Med Clin (Barc); 1992 Mar; 98(9):345-7. PubMed ID: 1374824
[No Abstract] [Full Text] [Related]
50. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
Bruce AW; Mahan DE
Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
[No Abstract] [Full Text] [Related]
51. [Treatment strategy for prostate cancer].
Kakehi Y
Nihon Rinsho; 2002 Dec; 60 Suppl 11():170-6. PubMed ID: 12599566
[No Abstract] [Full Text] [Related]
52. Measurement of prostate-specific antigen as a screening test for prostate cancer.
N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514
[No Abstract] [Full Text] [Related]
53. [Prostate cancer].
Hefermehl L; Elke B; Sulser T
Praxis (Bern 1994); 2010 Feb; 99(3):149-56, 158; quiz 157. PubMed ID: 20127633
[No Abstract] [Full Text] [Related]
54. [The specific prostatic antigen: an element of diagnostic conflict?].
Morote Robles J
Med Clin (Barc); 1992 Apr; 98(15):598. PubMed ID: 1376383
[No Abstract] [Full Text] [Related]
55. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
Morote J; de Torres JA
Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
[TBL] [Abstract][Full Text] [Related]
56. Relationship between prostate-specific antigen, clinical stage, and degree of bone metastasis in patients with prostate cancer: comparison with prostatic acid phosphatase and alkaline phosphatase.
Akimoto S; Furuya Y; Akakura K; Shimazaki J; Ito H
Int J Urol; 1997 Nov; 4(6):572-5. PubMed ID: 9477186
[TBL] [Abstract][Full Text] [Related]
57. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
Rainwater LM; Morgan WR; Klee GG; Zincke H
Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
[TBL] [Abstract][Full Text] [Related]
58. Relative value of prostate-specific antigen and prostatic acid phosphatase in diagnosis and management of adenocarcinoma of prostate. Ohio State University experience.
Drago JR; Badalament RA; Wientjes MG; Smith JJ; Nesbitt JA; York JP; Ashton JJ; Neff JC
Urology; 1989 Oct; 34(4):187-92. PubMed ID: 2477931
[TBL] [Abstract][Full Text] [Related]
59. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
[No Abstract] [Full Text] [Related]
60. Human prostatic acid phosphatase and prostate specific antigen: protein structure, gene organization, and expression in neoplastic and benign tissues.
Li SS
Kaohsiung J Med Sci; 1996 Aug; 12(8):441-7. PubMed ID: 8774111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
